Serological Detection of SARS-CoV-2 IgG Using Commercially Available Enzyme Immunoassays on Dried Blood Spots Collected from Patients
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Microbiology spectrum - 9(2021), 3 vom: 22. Dez., Seite e0124521 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Walker, Gregory J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Viral |
|---|
| Anmerkungen: |
Date Completed 05.01.2022 Date Revised 05.01.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1128/Spectrum.01245-21 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM334447534 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM334447534 | ||
| 003 | DE-627 | ||
| 005 | 20231225223721.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1128/Spectrum.01245-21 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1114.xml |
| 035 | |a (DE-627)NLM334447534 | ||
| 035 | |a (NLM)34908472 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Walker, Gregory J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Serological Detection of SARS-CoV-2 IgG Using Commercially Available Enzyme Immunoassays on Dried Blood Spots Collected from Patients |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.01.2022 | ||
| 500 | |a Date Revised 05.01.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a DBS | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a diagnostics | |
| 650 | 4 | |a dried blood spot | |
| 650 | 4 | |a serology | |
| 650 | 4 | |a virology | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 650 | 7 | |a Immunoglobulin G |2 NLM | |
| 700 | 1 | |a Davis, Rebecca |e verfasserin |4 aut | |
| 700 | 1 | |a Naing, Zin |e verfasserin |4 aut | |
| 700 | 1 | |a McEntee, Brad |e verfasserin |4 aut | |
| 700 | 1 | |a Lu, Yonghui |e verfasserin |4 aut | |
| 700 | 1 | |a Denadija, Tatijana |e verfasserin |4 aut | |
| 700 | 1 | |a Rawlinson, William D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Microbiology spectrum |d 2013 |g 9(2021), 3 vom: 22. Dez., Seite e0124521 |w (DE-627)NLM241847044 |x 2165-0497 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2021 |g number:3 |g day:22 |g month:12 |g pages:e0124521 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1128/Spectrum.01245-21 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2021 |e 3 |b 22 |c 12 |h e0124521 | ||